These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24821916)

  • 21. Antibacterial drug discovery: is small pharma the solution?
    Boggs AF; Miller GH
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The conformational musings of a medicinal chemist.
    Finch H
    Drug Discov Today; 2014 Mar; 19(3):320-5. PubMed ID: 24184532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinued drugs in 2010: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in antimicrobial drug development: implications for the future.
    Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
    Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Currently available antimicrobial agents and their potential for use as monotherapy.
    Peterson LR
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():30-45. PubMed ID: 19040464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 28. Something old, something new: revisiting natural products in antibiotic drug discovery.
    Wright GD
    Can J Microbiol; 2014 Mar; 60(3):147-54. PubMed ID: 24588388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of fundamental research and biotechnology in finding solutions to the global problem of antibiotic resistance.
    Hancock RE
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S148-50. PubMed ID: 8994796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming the current deadlock in antibiotic research.
    Schäberle TF; Hack IM
    Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The drug-resistant bacteria that pose the greatest health threats.
    Willyard C
    Nature; 2017 Feb; 543(7643):15. PubMed ID: 28252092
    [No Abstract]   [Full Text] [Related]  

  • 32. The antibiotic resistance crisis, with a focus on the United States.
    Martens E; Demain AL
    J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A three-step plan for antibiotics.
    Nature; 2014 May; 509(7502):533. PubMed ID: 24877183
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of novel IVD assays: a manufacturer's perspective.
    Metcalfe TA
    Scand J Clin Lab Invest Suppl; 2010; 242():23-6. PubMed ID: 20515272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug companies snub antibiotics as pipeline threatens to run dry.
    Clarke T
    Nature; 2003 Sep; 425(6955):225. PubMed ID: 13679874
    [No Abstract]   [Full Text] [Related]  

  • 36. (Some) current concepts in antibacterial drug discovery.
    van Geelen L; Meier D; Rehberg N; Kalscheuer R
    Appl Microbiol Biotechnol; 2018 Apr; 102(7):2949-2963. PubMed ID: 29455386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on the antibacterial resistance crisis.
    Croft AC; D'Antoni AV; Terzulli SL
    Med Sci Monit; 2007 Jun; 13(6):RA103-18. PubMed ID: 17534243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repairing the broken market for antibiotic innovation.
    Outterson K; Powers JH; Daniel GW; McClellan MB
    Health Aff (Millwood); 2015 Feb; 34(2):277-85. PubMed ID: 25646108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affairs of the Heart: Innovation in Cardiovascular Research and Development.
    Honig P; Terzic A
    Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Economic Conundrum for Antibacterial Drugs.
    Shlaes DM
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.